These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Soluble thrombomodulin levels in plasma of multiple sclerosis patients and their implication. Festoff BW, Li C, Woodhams B, Lynch S. J Neurol Sci; 2012 Dec 15; 323(1-2):61-5. PubMed ID: 22967748 [Abstract] [Full Text] [Related]
6. Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations. Praksova P, Stourac P, Bednarik J, Vlckova E, Mikulkova Z, Michalek J. J Neurol Sci; 2012 Aug 15; 319(1-2):18-23. PubMed ID: 22676847 [Abstract] [Full Text] [Related]
7. Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis. Sellner J, Koczi W, Harrer A, Oppermann K, Obregon-Castrillo E, Pilz G, Wipfler P, Afazel S, Haschke-Becher E, Trinka E, Kraus J. Clin Exp Immunol; 2013 Sep 15; 173(3):381-9. PubMed ID: 23611040 [Abstract] [Full Text] [Related]
8. Clinical and immune responses correlate in glatiramer acetate therapy of multiple sclerosis. Weder C, Baltariu GM, Wyler KA, Gober HJ, Lienert C, Schluep M, Radü EW, De Libero G, Kappos L, Duda PW. Eur J Neurol; 2005 Nov 15; 12(11):869-78. PubMed ID: 16241976 [Abstract] [Full Text] [Related]
10. Evaluating the response to glatiramer acetate in relapsing-remitting multiple sclerosis (RRMS) patients. Río J, Rovira A, Tintoré M, Sastre-Garriga J, Castilló J, Auger C, Nos C, Comabella M, Tur C, Vidal Á, Montalbán X. Mult Scler; 2014 Oct 15; 20(12):1602-8. PubMed ID: 24622350 [Abstract] [Full Text] [Related]
13. Multiple sclerosis: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo. Weber MS, Starck M, Wagenpfeil S, Meinl E, Hohlfeld R, Farina C. Brain; 2004 Jun 15; 127(Pt 6):1370-8. PubMed ID: 15090474 [Abstract] [Full Text] [Related]
14. Axonal metabolic recovery and potential neuroprotective effect of glatiramer acetate in relapsing-remitting multiple sclerosis. Khan O, Shen Y, Caon C, Bao F, Ching W, Reznar M, Buccheister A, Hu J, Latif Z, Tselis A, Lisak R. Mult Scler; 2005 Dec 15; 11(6):646-51. PubMed ID: 16320723 [Abstract] [Full Text] [Related]
15. The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis. Blauth K, Zhang X, Chopra M, Rogan S, Markovic-Plese S. Clin Immunol; 2015 Apr 15; 157(2):121-32. PubMed ID: 25596452 [Abstract] [Full Text] [Related]
20. Human and murine CD4 T cell reactivity to a complex antigen: recognition of the synthetic random polypeptide glatiramer acetate. Duda PW, Krieger JI, Schmied MC, Balentine C, Hafler DA. J Immunol; 2000 Dec 15; 165(12):7300-7. PubMed ID: 11120865 [Abstract] [Full Text] [Related] Page: [Next] [New Search]